Dr. Lombard is currently in private practice where his primary focus is on integrative medical approaches for ALS and other rare neurodegenerative diseases. He returned to practice after acting as the chief scientific officer and co-founder of Genomind, a genetic testing company focused on psychiatry. He is the author of several critically-acclaimed books, including his most recent publication Mind of God, Neuroscience, Faith and the Search for the Soul, which explored the intersection of spirituality and science. Dr. Lombard is also the author of several landmark studies, including the initial observation that subtypes of autism were mitochondrial based, which has been substantiated in subsequent studies. Dr. Lombard completed his neurology residency in 1995 and is the former chief of neurology at Westchester Square Medical Center and Bronx Lebanon Hospital.

We are pleased to present your October, 2021 issue of The Spelman Report: PhytoPharmacology Review. This month in our New Research Section (at 0:37), we discuss a study on crocus sativus for sleep. Plus, (at 9:27) the Topic of the Day continues our report on modes of activity for botanical medicines. Finally, (at 19:04) Dr. Spelman concludes the interview with Guido Masé, RH (AHG). We are very pleased to provide you the most up-to-date information on advancements in botanical science.

September, 2021 issue of The Spelman Report: PhytoPharmacology Review. This month our New Research Section (at 0:27), looks at cannabinoids for sleep. Additionally, (at 5:10) the Topic of the Day discusses modes of activity for botanical medicines. Wrapping up this issue, (at 29:53) Dr. Spelman interviews Guido Masé, RH (AHG). We are quite pleased to provide you the most up-to-date information on advancements in botanical science.

We are proud to present your August, 2021 issue of The Spelman Report: PhytoPharmacology Review. Beginning with our New Research Section this month (at 0:30), Dr. Spelman will present a study that looks at ozone as a therapy for COVID-19. Plus, (at 4:11) his Topic of the Day addresses various strategies for the management of depression with botanicals. Lastly, (at 25:46) his interview is with Scott Mendelson, MD. It is our mission to provide you the most up-to-date information on the progression of botanical science. As always, thanks so much for subscribing. We truly look forward to connecting with you again. Stay well.

In our New Research section this month (at 0:25), Dr. Spelman will cover a study on traditional chinese medicine (TCM) showing results in dealing with chronic obstructive pulmonary disease (COPD). Additionally, (at 5:30) his Topic of the Day discusses Alzheimer disease as well as micronutrients and phytonutrients. Lastly, (at 21:16) his interview is with Lillian Somner, DO. It is our endeavor to provide you the most up-to-date information on advancements in botanical science.

In our New Research section this month (at 0:30), Dr. Spelman reviews the Dietary Phytochemical Index and ADD/ADHD. Also, (at 9:00) his Topic of the Day discusses seizure disorders and CBD. Finally, (at 18:00) he will have an in-depth interview with Bonni Goldstein, MD.

Dr. Weiss became the first Cardiologist as a “Naturopathic Physician”, completing a non-invasive cardiovascular hospital-based training program in the Columbia Hospital system, the Arizona Heart Institute, and the Arizona Heart Hospital. Dr. Weiss kept privileges at the Arizona Heart Hospital, while opening the breakthrough Scottsdale Heart Institute, where he helped thousands of patients reduce medication safely, eliminate the need for angioplasty and bypass surgery, and reverse heart disease and many arrhythmias naturally. The International Association of Health Care Practitioners and the International Association of Cardiologists named Dr. Weiss, a “Leading Physician in the World” in 2012; a distinction given to under 1000 physicians each year. Dr. Weiss shifted focus to inflammation, genetics, and the science of intractable conflict, as he joined Artis International as a Senior Fellow and Director of their Center for Health and Medicine. In this capacity he has lectured, practiced medicine, and performed research throughout the various conflict zones (war zones), including Iraq, Lebanon, Israel, and Haiti.

We are proud to present your April, 2021 issue of The Spelman Report: PhytoPharmacology Review. In our New Research section this month (at 0:38), Dr. Spelman reviews the treatment of eczema with a topical solution of Sambucus ebulus. Additionally, (at 4:05) his Topic of the Day discusses polyphenols pleiotropic activity and Big Pharma’s reaction. Lastly, (at 24:21) he will conclude the interview with David Hoffmann, BSc, FNIMH, RH (AHG). We are so pleased to provide you the most up-to-date information on advancements in botanical science. As always, thank you so much for subscribing. We truly look forward to connecting with you again soon. Stay well.